OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma
Journal of Proteome Research · 01.08.2025 · 24 (8) · 4139-4153
DOI: 10.1021/acs.jproteome.5c00273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 21.07.2025. Verfasst von Yi-Hui Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academia Sinica, Ministry of Science and Technology, Taiwan, Center of Precision Medicine? from The Featured Areas Research Center Program.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10048, Taiwan.
- Graduate Institute of Medical Genomics and Proteomics, College of Medicine, National Taiwan University, Taipei 100233, Taiwan.
- Graduate Institute of Medical Science, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
- Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei 10002, Taiwan.
- Institute of Chemistry, Academia Sinica, Taipei 11529, Taiwan.
ORCID-Profile: Yi-Hui Huang, Wen-Hsin Chang, Chi-Ya Shen, Yu-Ju Chen, Sung-Liang Yu
Förderung
- Academia Sinica
- Ministry of Science and Technology, Taiwan
- Center of Precision Medicine? from The Featured Areas Research Center Program
- National Core Facility for Biopharmaceuticals
Zitieren
APA
Huang, Y. H., Chang, W. H., Shen, C. Y., Su, K. Y., Chang, G. C., Chen, J. S., Lee, W. Y., Chen, Y. J., & Yu, S. L. (2025). OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma. Journal of Proteome Research, 24(8), 4139-4153. https://doi.org/10.1021/acs.jproteome.5c00273
Vancouver
Huang YH, Chang WH, Shen CY, Su KY, Chang GC, Chen JS, et al. OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma. Journal of Proteome Research. 2025;24(8):4139-4153. doi:10.1021/acs.jproteome.5c00273
BibTeX
@article{Huang2025,
author = {Huang, Yi-Hui and Chang, Wen-Hsin and Shen, Chi-Ya and Su, Kang-Yi and Chang, Gee-Chen and Chen, Jin-Shing and Lee, Wen-Yao and Chen, Yu-Ju and Yu, Sung-Liang},
title = {OCIAD2 Promotes Cancer Progression via Metabolic Reprogramming in Lung Adenocarcinoma},
journal = {Journal of Proteome Research},
year = {2025},
volume = {24},
number = {8},
pages = {4139--4153},
doi = {10.1021/acs.jproteome.5c00273}
}
EUVIMED